Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

Overview of attention for article published in Journal of Clinical Oncology, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 4 news outlets
policy: 1 policy source
twitter: 23 X users

patent: 7 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 143 Mendeley

So far, Altmetric has seen 27 X posts from 23 X users, with an upper bound of 115,009 followers.

@QuinlanSievers @CharlesMilrod @MatthewHoMD @BrJHaem Another useful reference here: https://t.co/CGS9sliA9E

Hay cosas q no se pueden apurar.. Las sobrevidas a 10 años por ejemplo... Por más eficiente q sea tu estudio y novedosa sea tu droga tenes q esperar los 10 años

Absolutely

Despite the improvement in overall survival in patients with Follicular NHL in the rituximab era, their leading COD remains lymphoma, especially after disease transformation. RxRM also represents a concern, which supports the need for less-toxic therap…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 23 additional X posts.